Y.S.P.SOUTHEAST ASIA HOLDING

KLSE (MYR): YSPSAH (7178)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

2.27

Today's Change

+0.01 (0.44%)

Day's Change

2.27 - 2.27

Trading Volume

34,200

Financial

Show?
Last 10 FY Result
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 362,542 361,235 354,995 334,248 281,860 297,061 295,619 288,759 261,556 237,065 222,925 202,226 6.44%
PBT 39,240 41,723 53,822 47,693 22,493 30,263 31,832 42,304 29,688 36,317 39,527 25,230 8.77%
Tax -11,501 -12,774 -15,997 -12,920 -7,392 -8,104 -9,354 -12,171 -9,624 -8,399 -10,154 -8,139 7.79%
NP 27,738 28,949 37,825 34,773 15,101 22,159 22,478 30,133 20,064 27,918 29,373 17,091 9.22%
-
NP to SH 27,340 28,649 37,315 34,466 15,182 21,976 23,012 30,350 20,382 27,594 28,968 16,492 9.49%
-
Tax Rate 29.31% 30.62% 29.72% 27.09% 32.86% 26.78% 29.39% 28.77% 32.42% 23.13% 25.69% 32.26% -
Total Cost 334,804 332,286 317,170 299,475 266,759 274,902 273,141 258,626 241,492 209,147 193,552 185,135 6.16%
-
Net Worth 402,839 402,839 395,691 372,290 343,721 341,901 328,027 315,262 289,871 274,727 256,898 235,410 5.93%
Dividend
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 20,803 15,602 14,182 11,281 11,177 11,256 11,864 9,679 11,622 10,773 8,697 8,645 5.65%
Div Payout % 76.09% 54.46% 38.01% 32.73% 73.63% 51.22% 51.56% 31.89% 57.02% 39.04% 30.02% 52.42% -
Equity
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 402,839 402,839 395,691 372,290 343,721 341,901 328,027 315,262 289,871 274,727 256,898 235,410 5.93%
NOSH 141,844 141,844 141,844 141,034 140,899 140,700 139,583 138,301 136,746 134,670 133,801 133,000 0.71%
Ratio Analysis
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 7.65% 8.01% 10.66% 10.40% 5.36% 7.46% 7.60% 10.44% 7.67% 11.78% 13.18% 8.45% -
ROE 6.79% 7.11% 9.43% 9.26% 4.42% 6.43% 7.02% 9.63% 7.03% 10.04% 11.28% 7.01% -
Per Share
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 255.59 254.67 250.30 237.02 201.73 211.13 211.78 208.83 191.29 176.03 166.61 152.05 5.69%
EPS 19.28 20.20 26.37 24.45 10.87 15.68 16.54 22.05 15.01 20.49 21.65 12.40 8.73%
DPS 14.67 11.00 10.00 8.00 8.00 8.00 8.50 7.00 8.50 8.00 6.50 6.50 4.89%
NAPS 2.84 2.84 2.79 2.64 2.46 2.43 2.35 2.28 2.12 2.04 1.92 1.77 5.18%
Adjusted Per Share Value based on latest NOSH - 141,844
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 255.59 254.67 250.27 235.64 198.71 209.43 208.41 203.57 184.40 167.13 157.16 142.57 6.44%
EPS 19.28 20.20 26.31 24.30 10.70 15.49 16.22 21.40 14.37 19.45 20.42 11.63 9.48%
DPS 14.67 11.00 10.00 7.95 7.88 7.94 8.36 6.82 8.19 7.60 6.13 6.09 5.66%
NAPS 2.84 2.84 2.7896 2.6246 2.4232 2.4104 2.3126 2.2226 2.0436 1.9368 1.8111 1.6596 5.93%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 30/09/24 30/09/24 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 2.40 2.40 2.30 2.55 1.93 2.28 2.33 2.75 2.69 1.91 2.48 1.30 -
P/RPS 0.94 0.94 0.92 1.08 0.96 1.08 1.10 1.32 1.41 1.09 1.49 0.85 0.88%
P/EPS 12.45 11.88 8.74 10.43 17.76 14.60 14.13 12.53 18.05 9.32 11.45 10.48 -1.99%
EY 8.03 8.42 11.44 9.58 5.63 6.85 7.08 7.98 5.54 10.73 8.73 9.54 2.03%
DY 6.11 4.58 4.35 3.14 4.15 3.51 3.65 2.55 3.16 4.19 2.62 5.00 -1.53%
P/NAPS 0.85 0.85 0.82 0.97 0.78 0.94 0.99 1.21 1.27 0.94 1.29 0.73 1.29%
Price Multiplier on Announcement Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 22/11/24 22/11/24 27/02/24 27/02/23 25/02/22 25/02/21 25/02/20 26/02/19 28/02/18 22/02/17 26/02/16 27/02/15 -
Price 2.27 2.27 2.38 2.92 1.93 2.16 2.21 2.88 2.52 2.09 2.61 1.50 -
P/RPS 0.89 0.89 0.95 1.23 0.96 1.02 1.04 1.38 1.32 1.19 1.57 0.99 -0.45%
P/EPS 11.78 11.24 9.05 11.95 17.76 13.83 13.41 13.12 16.91 10.20 12.06 12.10 -3.17%
EY 8.49 8.90 11.05 8.37 5.63 7.23 7.46 7.62 5.92 9.80 8.30 8.27 3.27%
DY 6.46 4.85 4.20 2.74 4.15 3.70 3.85 2.43 3.37 3.83 2.49 4.33 -0.33%
P/NAPS 0.80 0.80 0.85 1.11 0.78 0.89 0.94 1.26 1.19 1.02 1.36 0.85 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
6 people like this. Showing 50 of 2,089 comments

wallstreetrookie

Guide to Investing in Bursa Healthcare 2022
1. Kotra Industries 2. YSP 3. ???

2022-04-02 21:53

UnicornP

Agreed with csan. Undervalued and going to be more undervalued!

2022-09-15 15:09

UnicornP

Creeping up

2022-10-31 10:32

wallstreetrookie

Buy-side has no more idea. They will pump all the healthcare stocks remaining

2022-11-04 11:22

wallstreetrookie

Just look at all the non-glove companies. They are all green

2022-11-04 11:22

UnicornP

Gross got up a bit, still good. Confident prospect.

2022-11-22 19:32

UnicornP

csan sell call

2022-12-01 16:40

Lightofheaven

Yes. Yes. Yes
Hold until next year Autumn for great harvest

2022-12-05 09:57

Lightofheaven

Y.S.P remain strong and healthy..all the way towards 2023

2022-12-12 16:23

Lightofheaven

walao ehh..wat happen to YSP
Suddenly surge to fly so high today!! Happy Happy

2022-12-13 12:48

Thkent91

Finally this share has released it's true potential power. I have been waiting years for it to shine

2023-01-03 19:55

wallstreetrookieNEW

Apex Healthcare + YSP + Kotra Industries = Dream Healthcare Portfolio 2023

2023-02-23 16:34

wallstreetrookieNEW

All in

2023-02-23 16:34

pang72

QR gostan?
So, largely pump and dump for HEALTHCARE recently

2023-02-27 19:11

value_seeker

Is the breakout sustainable?

2023-02-27 20:41

hhhiii123

What happen to the price when qtr result so good, any insider news?

2023-02-28 21:35

Nighelanghelo

someone keyed in 2.49 instead of 2.94?

2023-03-01 13:36

Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$€£¥

Security LastPr PE DY% Divcts ROE ttm-marg
YSPSAH (Pharmaceuticals) 2.35 9.63 3.4 8 9.25 10.3

2023-03-30 17:12

Lightofheaven

hold this for long term
hold this for dividen

2023-08-01 12:25

katara

good counter

2023-08-03 16:43

katara

no one interested?💙

2024-01-05 14:18

donald770

Qr result best ever. Should be due for upside rerating!!!

2024-05-22 15:53

BullishMarket

New Production line is started to be operated for the newly acquired factory premise. With the newly operated production line, the company's Revenue YoY % growth will be significantly increased within 2 years.

2024-05-22 18:51

Papayashot

Hi BullishMarket, from where you aware that New Production line is started to be operated for the newly acquired factory premise?

2024-05-22 20:15

SincereStock

bought a few at 2.85, acceptable bargain I think considering today open at RM3

2024-05-23 11:41

katara

mid term TP 330-450

2024-05-23 12:15

katara

today steady at 295😘

2024-05-23 16:34

katara

going to fly .. .. ..

2024-05-27 21:15

SincereStock

https://www.facebook.com/xngyuan/videos/828026755888524?idorvanity=3251240861803724

chenjian sifu commented YSPSAH positively

2024-06-03 22:07

TiffanixLVxHermes

reasons to buy:
1. recorded highest revenue and profit in 20years
2. organic growth, hold patents (expect to continue deliver good result)
3. DY 3.5% above RM0.11 ex 24/6/24

let's monitor
😎

2024-06-04 15:45

xiaoeh

Dear TLVH
may i know your entry price...?

2024-06-04 16:02

TiffanixLVxHermes

above 2.90 😎

2024-06-04 16:07

xiaoeh

Noted and Thanks for your sharing👍

2024-06-04 16:12

Up_down

Yspsah has been all the while being the lowest valuation company against its peers like Ahealth & Dpharma.

2024-06-06 10:44

katara

next monday 11 sen ex😍

2024-06-19 16:35

katara

https://www.cw.com.tw/article/5064201

2024-07-04 13:55

katara

https://www.youtube.com/watch?v=lII_oVFIun0

2024-07-04 13:56

katara

https://www.ctee.com.tw/news/20220714700772-439801
永信東南亞控股是台灣本土學名藥製藥廠中，第一家跨國上市的公司。這兩年，受疫情影響，年營收成長仍有3％〜5％。即將來臨的後疫情時代，李芳信預計，自2022年起，公司營收至少有雙位數以上的成長。

2024-07-04 13:57

SincereStock

waiting for reinvestent of dividend fund on 22 july 2024

2024-07-12 15:35

Learner68

Coming QR, looking forward for its new record high revenue and PBT...

2024-08-13 12:46

Learner68

Disappointing QR. Looking forward for 2nd half performance then.

2024-08-20 18:34

SincereStock

sold all YSPSAH at open price of 2.35 after very disaapointing QR (9.00am, 21 august 2024)

2024-08-21 09:15

katara

fundamental will support share price at around 2.50 b4 next Q...

2024-08-21 09:55

Learner68

For the first half of 2024, the Group's revenue rose 5.5% to RM184.8 million compared to RM175.2 million reported in the same period last year. The Group's profit before tax for 1H24 declined 17.0% to RM26.0 million from RM31.3 million in 1H23 due to higher unrealised foreign exchange loss was recorded resulted from strengthening of US Dollar.
Therefore, does that mean the stronger ringgit is in favour of YSP?

2024-08-21 14:51

katara

For the first half of 2023, the Group recorded a profit before tax of RM31.3 million compared to RM24.4 million in the same period last year mainly due to higher sales
from domestic and overseas market and foreign exchange gain resulted from weakening of the Ringgit against the US Dollar.
--Q2 2023😁

2024-08-23 15:13

Learner68

Katara, thanks! I guess it depends on the mix/geography of the sales. Anyway, good to see seriously buyback this round by Lees.

2 months ago

Papayashot

Q32024 quarter report: foreign exchange loss or (gain): (12,511)... This indicates 12 million of forex gain? But in their comments, they mentioned forex loss. The edge also mentioned 12 million forex loss.. (https://theedgemalaysia.com/node/734404)

Kinda confusing. Any comments guys?

5 days ago

Likesung

Other expenses are increased a lot .

4 days ago

Papayashot

In page 2 of 3QQR-2024, they indicate 12 million of forex gain.. Quite confusing.. Dunno it is typo or what

4 days ago

Likesung

Yup, they make a correction on QR so u can study again

2 days ago

Post a Comment